Dose reduction of baricitinib in patients with rheumatoid arthritis achieving sustained disease control: Results of a prospective study
Takeuchi T et al. Ann Rheum Dis 2018. doi: 10.1136/annrheumdis-2018-213271
Please follow the link below to view this article in full on a third-party website. Note that a subscription or payment may be required.